Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Alzheimers Dis ; 93(4): 1425-1441, 2023.
Article in English | MEDLINE | ID: mdl-37182881

ABSTRACT

BACKGROUND: In Alzheimer's disease (AD) brain, neuronal polarity and synaptic connectivity are compromised. A key structure for regulating polarity and functions of neurons is the axon initial segment (AIS), which segregates somatodendritic from axonal proteins and initiates action potentials. Toxic tau species, including extracellular oligomers (xcTauOs), spread tau pathology from neuron to neuron by a prion-like process, but few other cell biological effects of xcTauOs have been described. OBJECTIVE: Test the hypothesis that AIS structure is sensitive to xcTauOs. METHODS: Cultured wild type (WT) and tau knockout (KO) mouse cortical neurons were exposed to xcTauOs, and quantitative western blotting and immunofluorescence microscopy with anti-TRIM46 monitored effects on the AIS. The same methods were used to compare TRIM46 and two other resident AIS proteins in human hippocampal tissue obtained from AD and age-matched non-AD donors. RESULTS: Without affecting total TRIM46 levels, xcTauOs reduce the concentration of TRIM46 within the AIS and cause AIS shortening in cultured WT, but not TKO neurons. Lentiviral-driven tau expression in tau KO neurons rescues AIS length sensitivity to xcTauOs. In human AD hippocampus, the overall protein levels of multiple resident AIS proteins are unchanged compared to non-AD brain, but TRIM46 concentration within the AIS and AIS length are reduced in neurons containing neurofibrillary tangles. CONCLUSION: xcTauOs cause partial AIS damage in cultured neurons by a mechanism dependent on intracellular tau, thereby raising the possibility that the observed AIS reduction in AD neurons in vivo is caused by xcTauOs working in concert with endogenous neuronal tau.


Subject(s)
Alzheimer Disease , Axon Initial Segment , Mice , Animals , Humans , Axon Initial Segment/metabolism , Axon Initial Segment/pathology , Axons/pathology , Neurons/metabolism , Alzheimer Disease/pathology , Hippocampus/pathology , Mice, Knockout , tau Proteins/genetics , tau Proteins/metabolism
2.
Neurobiol Dis ; 169: 105737, 2022 07.
Article in English | MEDLINE | ID: mdl-35452786

ABSTRACT

Altered mitochondrial DNA (mtDNA) occurs in neurodegenerative disorders like Alzheimer's disease (AD); how mtDNA synthesis is linked to neurodegeneration is poorly understood. We previously discovered Nutrient-induced Mitochondrial Activity (NiMA), an inter-organelle signaling pathway where nutrient-stimulated lysosomal mTORC1 activity regulates mtDNA replication in neurons by a mechanism sensitive to amyloid-ß oligomers (AßOs), a primary factor in AD pathogenesis (Norambuena et al., 2018). Using 5-ethynyl-2'-deoxyuridine (EdU) incorporation into mtDNA of cultured neurons, along with photoacoustic and mitochondrial metabolic imaging of cultured neurons and mouse brains, we show these effects being mediated by mTORC1-catalyzed T40 phosphorylation of superoxide dismutase 1 (SOD1). Mechanistically, tau, another key factor in AD pathogenesis and other tauopathies, reduced the lysosomal content of the tuberous sclerosis complex (TSC), thereby increasing NiMA and suppressing SOD1 activity and mtDNA synthesis. AßOs inhibited these actions. Dysregulation of mtDNA synthesis was observed in fibroblasts derived from tuberous sclerosis (TS) patients, who lack functional TSC and elevated SOD1 activity was also observed in human AD brain. Together, these findings imply that tau and SOD1 couple nutrient availability to mtDNA replication, linking mitochondrial dysfunction to AD.


Subject(s)
Alzheimer Disease , Amyloid beta-Peptides , Superoxide Dismutase-1 , Tuberous Sclerosis , Alzheimer Disease/enzymology , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/metabolism , Animals , DNA, Mitochondrial/genetics , DNA, Mitochondrial/metabolism , Humans , Lysosomes/genetics , Lysosomes/metabolism , Mechanistic Target of Rapamycin Complex 1/metabolism , Mice , Mitochondria/metabolism , Superoxide Dismutase-1/genetics , Superoxide Dismutase-1/metabolism , Tuberous Sclerosis/enzymology , Tuberous Sclerosis/genetics
3.
EMBO J ; 37(22)2018 11 15.
Article in English | MEDLINE | ID: mdl-30348864

ABSTRACT

The mechanisms of mitochondrial dysfunction in Alzheimer's disease are incompletely understood. Using two-photon fluorescence lifetime microscopy of the coenzymes, NADH and NADPH, and tracking brain oxygen metabolism with multi-parametric photoacoustic microscopy, we show that activation of lysosomal mechanistic target of rapamycin complex 1 (mTORC1) by insulin or amino acids stimulates mitochondrial activity and regulates mitochondrial DNA synthesis in neurons. Amyloid-ß oligomers, which are precursors of amyloid plaques in Alzheimer's disease brain and stimulate mTORC1 protein kinase activity at the plasma membrane but not at lysosomes, block this Nutrient-induced Mitochondrial Activity (NiMA) by a mechanism dependent on tau, which forms neurofibrillary tangles in Alzheimer's disease brain. NiMA was also disrupted in fibroblasts derived from two patients with tuberous sclerosis complex, a genetic disorder that causes dysregulation of lysosomal mTORC1. Thus, lysosomal mTORC1 couples nutrient availability to mitochondrial activity and links mitochondrial dysfunction to Alzheimer's disease by a mechanism dependent on the soluble building blocks of the poorly soluble plaques and tangles.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Lysosomes/metabolism , Mitochondria/metabolism , Signal Transduction , Tuberous Sclerosis/metabolism , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Amyloid beta-Peptides/genetics , Animals , Brain/metabolism , Brain/pathology , Cell Membrane/genetics , Cell Membrane/metabolism , Cell Membrane/pathology , Fibroblasts/metabolism , Fibroblasts/pathology , Humans , Lysosomes/genetics , Lysosomes/pathology , Mechanistic Target of Rapamycin Complex 1/genetics , Mechanistic Target of Rapamycin Complex 1/metabolism , Mice , Mitochondria/genetics , Mitochondria/pathology , Tuberous Sclerosis/genetics , Tuberous Sclerosis/pathology
4.
Methods Mol Biol ; 945: 329-45, 2013.
Article in English | MEDLINE | ID: mdl-23097116

ABSTRACT

The kidney is a highly heterogeneous organ that is responsible for fluid and electrolyte balance. Much interest is focused on determining the function of specific renal epithelial cells in humans, which can only be accomplished through the isolation and growth of nephron segment-specific epithelial cells. However, human renal epithelial cells are notoriously difficult to maintain in culture. This chapter describes the isolation, growth, immortalization, and characterization of the human renal proximal tubule cell. In addition, we describe new paradigms in 3D cell culture which allow the cells to maintain more in vivo-like morphology and function.


Subject(s)
Cell Culture Techniques/methods , Cell Separation/methods , Epithelial Cells/cytology , Kidney Tubules, Proximal/cytology , Adenoviridae/genetics , Antigens, Polyomavirus Transforming/genetics , Cell Proliferation , Cryopreservation , Epithelial Cells/metabolism , HEK293 Cells , Humans , Lentivirus/genetics , Telomerase/genetics , Transduction, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...